Julius J Schmidt

InstitutionHannover Medical School
AddressHannover
Germany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 1 publications in July 2020 and February 2021 and March 2021 and July 2021 and Spetember 2021
    All Publications
    Bar chart showing 28 publications over 9 distinct years, with a maximum of 8 publications in 2015
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Birnhuber A, Fließer E, Gorkiewicz G, Zacharias M, Seeliger B, David S, Welte T, Schmidt J, Olschewski H, Wygrecka M, Kwapiszewska G. Between inflammation and thrombosis: endothelial cells in COVID-19. Eur Respir J. 2021 09; 58(3). PMID: 33958433.
      Citations: 2     Fields:    Translation:HumansCells
    2. Schmidt JJ, Bode-Böger SM, Martens-Lobenhoffer J, Hoeper MM, Kielstein JT. Pharmacokinetics of Remdesivir and GS-441524 during PIRRT and Seraph 100 Therapy. Clin J Am Soc Nephrol. 2021 08; 16(8):1256-1257. PMID: 34301737.
      Citations:    Fields:    Translation:Humans
    3. Schultz B, Krauß T, Schmidt M, Schultz M, Schneider A, Wiesner O, Schmidt JJ, Stahl K, David S, Hoeper MM, Busch M. High Incidence of Epileptiform Potentials During Continuous EEG Monitoring in Critically Ill COVID-19 Patients. Front Med (Lausanne). 2021; 8:613951. PMID: 33842496.
      Citations:    
    4. Bonifacius A, Tischer-Zimmermann S, Dragon AC, Gussarow D, Vogel A, Krettek U, Gödecke N, Yilmaz M, Kraft ARM, Hoeper MM, Pink I, Schmidt JJ, Li Y, Welte T, Maecker-Kolhoff B, Martens J, Berger MM, Lobenwein C, Stankov MV, Cornberg M, David S, Behrens GMN, Witzke O, Blasczyk R, Eiz-Vesper B. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses. Immunity. 2021 02 09; 54(2):340-354.e6. PMID: 33567252.
      Citations: 40     Fields:    Translation:HumansCells
    5. Seffer MT, Martens-Lobenhoffer J, Schmidt JJ, Eden G, Bode-Böger SM, Kielstein JT. Clearance of chloroquine and hydroxychloroquine by the Seraph® 100 Microbinda Affinity Blood Filter -a device approved for the treatment of COVID-19 patients. Ther Apher Dial. 2021 Apr; 25(2):237-241. PMID: 32558210.
      Citations: 2     Fields:    Translation:Humans
    6. Stahl K, Schenk H, Seeliger B, Wiesner O, Schmidt JJ, Bauersachs J, Welte T, Kühn C, Haverich A, Hoeper MM, David S. Extracorporeal membrane oxygenation for acute respiratory distress syndrome due to Pneumocystis pneumonia. Eur Respir J. 2019 09; 54(3). PMID: 31151957.
      Citations: 3     Fields:    Translation:Humans
    7. Schmidt JJ, Strunk AK, David S, Bode-Böger SM, Martens-Lobenhoffer J, Knitsch W, Scherneck S, Welte T, Kielstein JT. Single- and multiple-dose pharmacokinetics and total removal of colistin in critically ill patients with acute kidney injury undergoing prolonged intermittent renal replacement therapy. J Antimicrob Chemother. 2019 04 01; 74(4):997-1002. PMID: 30624668.
      Citations: 4     Fields:    Translation:Humans
    8. Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, Eder M, Welte T, Hoeper MM, Scherag A, David S. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care. 2018 11 19; 22(1):307. PMID: 30454031.
      Citations: 19     Fields:    Translation:HumansAnimals
    9. Economou CJP, Kielstein JT, Czock D, Xie J, Field J, Richards B, Tallott M, Visser A, Koenig C, Hafer C, Schmidt JJ, Lipman J, Roberts JA. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy. Int J Antimicrob Agents. 2018 Aug; 52(2):151-157. PMID: 29526606.
      Citations: 4     Fields:    Translation:Humans
    10. Schmidt JJ, Asper F, Einecke G, Eden G, Hafer C, Kielstein JT. Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments - a one-year retrospective analysis. BMC Nephrol. 2018 01 15; 19(1):12. PMID: 29334938.
      Citations: 4     Fields:    Translation:Humans
    11. Schmidt JJ, Bode-Böger SM, Wilhelmi M, Omar M, Martens-Lobenhoffer J, Welte T, Kielstein JT. Pharmacokinetics and total removal of fosfomycin in two patients undergoing intermittent haemodialysis and extended dialysis: prescription needs to avoid under-dosing. J Antimicrob Chemother. 2016 09; 71(9):2673-4. PMID: 27272722.
      Citations: 2     Fields:    Translation:HumansCells
    12. Arelin V, Schmidt JJ, Kayser N, Kühn-Velten WN, Suhling H, Eden G, Kielstein JT. Removal of methadone by extended dialysis using a high cut-off dialyzer: implications for the treatment of overdose and for pain management in patients undergoing light chain removal. Clin Nephrol. 2016 Jun; 85(6):353-7. PMID: 27116939.
      Citations: 1     Fields:    Translation:Humans
    13. Schmidt JJ, Ramazan L, Bockemeyer C, Günter HH, Martens-Lobenhoffer J, Ganzenmüller T, Bode-Böger SM, Kielstein JT. Acute interstitial nephritis due to flecainide therapy in the 38(th) week of pregnancy. BMC Nephrol. 2016 Mar 15; 17:28. PMID: 26980436.
      Citations:    Fields:    Translation:Humans
    14. Hafer C, Golla P, Gericke M, Eden G, Beutel G, Schmidt JJ, Schmidt BM, De Reys S, Kielstein JT. Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study. Int Urol Nephrol. 2016 Jan; 48(1):133-8. PMID: 26531062.
      Citations: 9     Fields:    Translation:Humans
    15. Strunk AK, Ciesek S, Schmidt JJ, Kühn C, Hoeper MM, Welte T, Kielstein JT. Single- and multiple-dose pharmacokinetics of ethambutol and rifampicin in a tuberculosis patient with acute respiratory distress syndrome undergoing extended daily dialysis and ECMO treatment. Int J Infect Dis. 2016 Jan; 42:1-3. PMID: 26518065.
      Citations: 2     Fields:    Translation:Humans
    16. Schmidt JJ, Jahn J, Golla P, Hafer C, Kielstein JT, Kielstein H. Effect of therapeutic plasma exchange on plasma levels and total removal of adipokines and inflammatory markers. BMC Obes. 2015; 2:37. PMID: 26425347.
      Citations: 3     
    17. Schmidt JJ, Bertram A, Kühn-Velten WN, Suhling H, Wiesner O, Schneider A, Kielstein JT. Treatment of amitriptyline intoxications by extended high cut-off dialysis. Clin Kidney J. 2015 Dec; 8(6):796-9. PMID: 26613042.
      Citations: 2     
    18. Kielstein JT, Schmidt JJ. Ceftolozane-tazobactam versus levofloxacin in urinary tract infection. Lancet. 2015 Sep 26; 386(10000):1241. PMID: 26460656.
      Citations:    Fields:    Translation:Humans
    19. Baroke E, Schmidt JJ, Strunk AK, Wiesner O, Kühn-Velten WN, Kielstein JT. Saving two lives with one dialysis treatment. Clin Nephrol. 2015 Aug; 84(2):104-7. PMID: 25600858.
      Citations: 1     Fields:    Translation:Humans
    20. Schmidt JJ, Kielstein JT. [Three shades of fluids: Bergström 2.0?/?Furosemide stress test?/?replacement fluid for therapeutic plasma exchange]. Dtsch Med Wochenschr. 2015 Jun; 140(12):897-9. PMID: 26069915.
      Citations: 1     Fields:    Translation:Humans
    21. Schmidt JJ, Beutel G, Kielstein JT. [Diagnosis and pathophysiology of acute renal failure - is prevention possible?]. Dtsch Med Wochenschr. 2015 Feb; 140(4):245-9. PMID: 25704519.
      Citations:    Fields:    Translation:Humans
    22. Schmidt JJ, Lorenzen J, Chatzikyrkou C, Lichtinghagen R, Kielstein JT. Total collected dialysate lithium concentration after successful dialysis treatment in case of intoxication. BMC Pharmacol Toxicol. 2014 Sep 06; 15:49. PMID: 25193402.
      Citations: 2     Fields:    Translation:Humans
    23. Strunk AK, Schmidt JJ, Baroke E, Bode-Böger SM, Martens-Lobenhoffer J, Welte T, Kielstein JT. Single- and multiple-dose pharmacokinetics and total removal of colistin in a patient with acute kidney injury undergoing extended daily dialysis. J Antimicrob Chemother. 2014 Jul; 69(7):2008-10. PMID: 24651826.
      Citations: 8     Fields:    Translation:Humans
    24. Schmidt JJ, Hafer C, Spielmann J, Hadem J, Schönenberger E, Schmidt BM, Kielstein JT. Removal characteristics and total dialysate content of glutamine and other amino acids in critically ill patients with acute kidney injury undergoing extended dialysis. Nephron Clin Pract. 2014; 126(1):62-6. PMID: 24577340.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    25. Clajus C, Kühn-Velten WN, Schmidt JJ, Lorenzen JM, Pietsch D, Beutel G, Kielstein JT. Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations. BMC Pharmacol Toxicol. 2013 Apr 03; 14:19. PMID: 23551893.
      Citations: 6     Fields:    Translation:Humans
    26. Reising A, Sambale S, Donnerstag F, Schmidt JJ, Hafer C, Schmidt BM, Kielstein JT. Effect of isovolemic, isothermic hemodialysis on cerebral perfusion and vascular stiffness using contrast computed tomography and pulse wave velocity. PLoS One. 2013; 8(2):e56396. PMID: 23451044.
      Citations: 3     Fields:    Translation:Humans
    27. Schmidt JJ, Hafer C, Clajus C, Hadem J, Beutel G, Schmidt BM, Kielstein JT. New high-cutoff dialyzer allows improved middle molecule clearance without an increase in albumin loss: a clinical crossover comparison in extended dialysis. Blood Purif. 2012; 34(3-4):246-52. PMID: 23171639.
      Citations: 11     Fields:    Translation:Humans
    28. Martino F, Lorenzen J, Schmidt J, Schmidt M, Broll M, Görzig Y, Kielstein JT, Thum T. Circulating microRNAs are not eliminated by hemodialysis. PLoS One. 2012; 7(6):e38269. PMID: 22715378.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials